Meeting
2014 ASCO Annual Meeting
Relation of genes in estrogen and vitamin D signaling to bone mineral density loss in aromatase inhibitors treatment.
Authors
Sonia Servitja
Medical Oncology Department. Hospital del Mar, Barcelona, Spain
Sonia Servitja , Maria Rodriguez-Sanz , Natalia Garcia-Giralt , Elisabet Torres , Dani Prieto-Alhambra , Leonardo Mellibovsky , Ignacio Tusquets , Adolf Diez-Perez , Xavi Nogues
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 575)
DOI
10.1200/jco.2014.32.15_suppl.575
Abstract #
575
Poster Bd #
39
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Association of a low-expression SLCO1B1 polymorphism with estrogen concentrations before and during aromatase inhibitor treatment for breast cancer.
First Author: Jacqueline M Dempsey
Poster
2017 ASCO Annual Meeting
Association of baseline plasma levels of 25OH vitamin D and breast cancer risk in a chemoprevention trial.
First Author: Bernardo Bonanni
Poster
2016 ASCO Annual Meeting
Tamoxifen versus aromatase inhibitors for the adjuvant treatment of breast cancer in older women: A feasibility study to examine differences in cognitive outcomes.
First Author: Emily Anne Underwood
Poster
2016 ASCO Annual Meeting
Polymorphisms of genes encoding for vitamin D binding protein and Wnt5a to predict outcome for mCRC patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial.
First Author: Martin D. Berger